These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit. Brinkley DM; Burpee LJ; Chaudhry SP; Smallwood JA; Lindenfeld J; Lakdawala NK; Desai AS; Stevenson LW J Card Fail; 2018 Jun; 24(6):349-354. PubMed ID: 29410227 [TBL] [Abstract][Full Text] [Related]
26. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF. Voors AA; Davison BA; Teerlink JR; Felker GM; Cotter G; Filippatos G; Greenberg BH; Pang PS; Levin B; Hua TA; Severin T; Ponikowski P; Metra M; Eur J Heart Fail; 2014 Nov; 16(11):1230-40. PubMed ID: 25287144 [TBL] [Abstract][Full Text] [Related]
27. Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure. Guzik M; Iwanek G; Fudim M; Zymliński R; Marciniak D; Ponikowski P; Biegus J Sci Rep; 2024 Jan; 14(1):1494. PubMed ID: 38233473 [TBL] [Abstract][Full Text] [Related]
28. Diuretic resistance in acute heart failure: proposal for a new urinary sodium-based definition. Pellegrino M; Villaschi A; Gasparini G; Maccallini M; Pinto G; Pini D Int J Cardiol; 2024 Nov; 415():132456. PubMed ID: 39151483 [TBL] [Abstract][Full Text] [Related]
29. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. AbouEzzeddine OF; Wong YW; Mentz RJ; Raza SS; Nativi-Nicolau J; Kociol RD; McNulty SE; Anstrom KJ; Hernandez AF; Redfield MM; J Card Fail; 2016 Nov; 22(11):853-858. PubMed ID: 26718344 [TBL] [Abstract][Full Text] [Related]
31. Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction. Matsue Y; Suzuki M; Torii S; Yamaguchi S; Fukamizu S; Ono Y; Fujii H; Kitai T; Nishioka T; Sugi K; Onishi Y; Noda M; Kagiyama N; Satoh Y; Yoshida K; Goldsmith SR J Card Fail; 2016 Jun; 22(6):423-32. PubMed ID: 26915749 [TBL] [Abstract][Full Text] [Related]
32. Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). Grodin JL; Gallup D; Anstrom KJ; Felker GM; Chen HH; Tang WHW Am J Cardiol; 2017 Jun; 119(12):2003-2009. PubMed ID: 28433216 [TBL] [Abstract][Full Text] [Related]
33. Spot urine sodium in acute heart failure: differences in prognostic value on admission and discharge. Biegus J; Zymliński R; Fudim M; Testani J; Sokolski M; Marciniak D; Ponikowska B; Guzik M; Garus M; Urban S; Ponikowski P ESC Heart Fail; 2021 Aug; 8(4):2597-2602. PubMed ID: 33932273 [TBL] [Abstract][Full Text] [Related]
34. Spot urinary sodium guided titration of intravenous diuretic therapy in acute heart failure: A pilot randomised controlled trial. Khorramshahi Bayat M; Chan W; Hay K; McKenzie S; Adhikari P; Fincher G; Jordan F; Ranasinghe I Eur Heart J Qual Care Clin Outcomes; 2024 Apr; ():. PubMed ID: 38632053 [TBL] [Abstract][Full Text] [Related]
35. Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction. Palazzuoli A; Pellegrini M; Franci B; Beltrami M; Ruocco G; Gonnelli S; Angelini GD; Nuti R Intern Emerg Med; 2015 Feb; 10(1):41-9. PubMed ID: 25087085 [TBL] [Abstract][Full Text] [Related]
36. Is there still a role for low-dose dopamine use in acute heart failure? Torres-Courchoud I; Chen HH Curr Opin Crit Care; 2014 Oct; 20(5):467-71. PubMed ID: 25137402 [TBL] [Abstract][Full Text] [Related]
37. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis. Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531 [TBL] [Abstract][Full Text] [Related]
38. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure. Cox ZL; Collins SP; Hernandez GA; McRae AT; Davidson BT; Adams K; Aaron M; Cunningham L; Jenkins CA; Lindsell CJ; Harrell FE; Kampe C; Miller KF; Stubblefield WB; Lindenfeld J J Am Coll Cardiol; 2024 Apr; 83(14):1295-1306. PubMed ID: 38569758 [TBL] [Abstract][Full Text] [Related]
40. Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database. Gradman AH; Vekeman F; Eldar-Lissai A; Trahey A; Ong SH; Duh MS J Card Fail; 2014 Nov; 20(11):853-63. PubMed ID: 25152497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]